{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T20:25:22Z","timestamp":1793219122833,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04386-w","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:50:04Z","timestamp":1762339804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ustekinumab enhances intestinal stenosis resolution by modulating fibrotic pathways in Crohn\u2019s disease: a retrospective single-center study with translational analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Rieko","family":"Nakata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8808-5672","authenticated-orcid":false,"given":"Shuhei","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumie","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ominami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nadatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusei","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunari","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"4386_CR1","doi-asserted-by":"crossref","unstructured":"Tsai L, Ma C, Dulai PS, Prokop LJ, Eisenstein S, Ramamoorthy SL et al. Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn\u2019s Disease: A Meta-Analysis of Population-Based Cohorts. Clin Gastroenterol Hepatol. 2021;19(10):2031-45.e11.","DOI":"10.1016\/j.cgh.2020.10.039"},{"issue":"10342","key":"4386_CR2","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1016\/S0140-6736(22)00688-2","volume":"399","author":"BE Sands","year":"2022","unstructured":"Sands BE, Irving PM, Hoops T, Izanec JL, Gao L-L, Gasink C, et al. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn\u2019s disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial. Lancet. 2022;399(10342):2200\u201311.","journal-title":"Lancet"},{"issue":"5","key":"4386_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.14740\/gr1194","volume":"12","author":"Z Ahmed","year":"2019","unstructured":"Ahmed Z, Venkata K, Zhang N, Malik TA. Comparative effectiveness of ustekinumab versus adalimumab in induction of clinical response and remission in Crohn\u2019s disease: experience of a real-world cohort at a tertiary care inflammatory bowel disease referral center. Gastroenterol Res. 2019;12(5):245\u201351.","journal-title":"Gastroenterol Res"},{"issue":"13","key":"4386_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s40265-023-01916-2","volume":"83","author":"JP Gisbert","year":"2023","unstructured":"Gisbert JP, Chaparro M. Anti-TNF agents and new biological agents (Vedolizumab and Ustekinumab) in the prevention and treatment of postoperative recurrence after surgery in Crohn\u2019s disease. Drugs. 2023;83(13):1179\u2013205.","journal-title":"Drugs"},{"issue":"5","key":"4386_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1136\/gut.34.5.647","volume":"34","author":"D Lescut","year":"1993","unstructured":"Lescut D, Vanco D, Bonni\u00e8re P, Lecomte-Houcke M, Quandalle P, Wurtz A, et al. Perioperative endoscopy of the whole small bowel in crohn\u2019s disease. Gut. 1993;34(5):647\u20139.","journal-title":"Gut"},{"key":"4386_CR6","doi-asserted-by":"crossref","unstructured":"Peyrin-Biroulet L, Loftus EV Jr., Colombel J-F, Sandborn WJ. The Natural History of Adult Crohn\u2019s Disease in Population-Based Cohorts. Official J Am Coll Gastroenterol | ACG. 2010;105(2):289\u2013297.","DOI":"10.1038\/ajg.2009.579"},{"issue":"1","key":"4386_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00535-020-01737-0","volume":"56","author":"K Takabayashi","year":"2021","unstructured":"Takabayashi K, Hosoe N, Kato M, Hayashi Y, Nanki K, Fukuhara K, et al. Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn\u2019s disease in clinical remission. J Gastroenterol. 2021;56(1):25\u201333.","journal-title":"J Gastroenterol"},{"issue":"5","key":"4386_CR8","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160(5):1570\u201383.","journal-title":"Gastroenterology"},{"key":"4386_CR9","doi-asserted-by":"crossref","unstructured":"Takenaka K, Ohtsuka K, Kitazume Y, Matsuoka K, Nagahori M, Fujii T et al. Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn\u2019s Disease. Official J Am Coll Gastroenterol | ACG. 2018;113(2).","DOI":"10.1038\/ajg.2017.464"},{"key":"4386_CR10","volume":"2020","author":"J Torle","year":"2020","unstructured":"Torle J, Dabir PD, Korsgaard U, Christiansen J, Qvist N, El-Hussuna A. Levels of intestinal inflammation and fibrosis in resection specimens after preoperative anti-tumor necrosis factor alpha treatment in patients with crohn\u2019s disease: a comparative pilot study. Surg Res Pract. 2020;2020:6085678.","journal-title":"Surg Res Pract"},{"issue":"5","key":"4386_CR11","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","volume":"116","author":"G D\u2019Haens","year":"1999","unstructured":"D\u2019Haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F, et al. Endoscopic and histological healing with Infliximab anti\u2013tumor necrosis factor antibodies in crohn\u2019s disease: A European multicenter trial. Gastroenterology. 1999;116(5):1029\u201334.","journal-title":"Gastroenterology"},{"issue":"6","key":"4386_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00535-020-01670-2","volume":"55","author":"S Bamba","year":"2020","unstructured":"Bamba S, Sakemi R, Fujii T, Takeda T, Fujioka S, Takenaka K, et al. A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn\u2019s disease. J Gastroenterol. 2020;55(6):615\u201326.","journal-title":"J Gastroenterol"},{"key":"4386_CR13","doi-asserted-by":"crossref","unstructured":"Lichtenstein GR, Olson A, Travers S, Diamond RH, Chen DM, Pritchard ML et al. Factors Associated with the Development of Intestinal Strictures or Obstructions in Patients with Crohn\u2019s Disease. Official J Am Coll Gastroenterol | ACG. 2006;101(5).","DOI":"10.1111\/j.1572-0241.2006.00463.x"},{"issue":"4","key":"4386_CR14","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.crohns.2012.04.008","volume":"7","author":"I Drygiannakis","year":"2013","unstructured":"Drygiannakis I, Valatas V, Sfakianaki O, Bourikas L, Manousou P, Kambas K, et al. Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis. J Crohns Colitis. 2013;7(4):286\u2013300.","journal-title":"J Crohns Colitis"},{"issue":"43","key":"4386_CR15","doi-asserted-by":"publisher","first-page":"36099","DOI":"10.1074\/jbc.M505291200","volume":"280","author":"AL Theiss","year":"2005","unstructured":"Theiss AL, Simmons JG, Jobin C, Lund PK. Tumor necrosis factor (TNF) \u03b1 increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2 *. J Biol Chem. 2005;280(43):36099\u2013109.","journal-title":"J Biol Chem"},{"key":"4386_CR16","doi-asserted-by":"crossref","unstructured":"Curciarello R, Docena GH, MacDonald TT. The role of cytokines in the fibrotic responses in crohn\u2019s disease. Front Med. 2017;4:126.","DOI":"10.3389\/fmed.2017.00126"},{"key":"4386_CR17","doi-asserted-by":"crossref","unstructured":"Matsumoto H, Hata J, Imuamura H, Yo S, Sasahira M, et al. Serial changes in intestinal stenotic stiffness in patients with Crohn\u2019s disease treated with biologics: a pilot study using ultrasound shear wave elastography. Turk J Gastroenterol. 2023;34(10):1006\u201313.","DOI":"10.5152\/tjg.2023.22768"},{"issue":"9","key":"4386_CR18","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/ibd\/izy142","volume":"24","author":"Q Guan","year":"2018","unstructured":"Guan Q, Weiss CR, Wang S, Qing G, Yang X, Warrington RJ, et al. Reversing ongoing chronic intestinal inflammation and fibrosis by sustained block of IL-12 and IL-23 using a vaccine in mice. Inflamm Bowel Dis. 2018;24(9):1941\u201352.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"4386_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1053\/j.gastro.2014.04.008","volume":"147","author":"K Takenaka","year":"2014","unstructured":"Takenaka K, Ohtsuka K, Kitazume Y, Nagahori M, Fujii T, Saito E, et al. Comparison of magnetic resonance and balloon enteroscopic examination of the small intestine in patients with crohn\u2019s disease. Gastroenterology. 2014;147(2):334\u2013e423.","journal-title":"Gastroenterology"},{"issue":"8","key":"4386_CR20","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1097\/MIB.0000000000000449","volume":"21","author":"K Takenaka","year":"2015","unstructured":"Takenaka K, Ohtsuka K, Kitazume Y, Nagahori M, Fujii T, Saito E, et al. Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in crohn\u2019s disease. Inflamm Bowel Dis. 2015;21(8):1832\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"12","key":"4386_CR21","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.7863\/ultra.33.12.2115","volume":"33","author":"JR Dillman","year":"2014","unstructured":"Dillman JR, Stidham RW, Higgins PDR, Moons DS, Johnson LA, Keshavarzi NR, et al. Ultrasound shear wave elastography helps discriminate low-grade from high-grade bowel wall fibrosis in ex vivo human intestinal specimens. J Ultrasound Med. 2014;33(12):2115\u201323.","journal-title":"J Ultrasound Med"},{"issue":"2","key":"4386_CR22","first-page":"69","volume":"209","author":"C-J Xu","year":"2013","unstructured":"Xu C-J, Mikami T, Nakamura T, Tsuruta T, Nakada N, Yanagisawa N, et al. Tumor budding, myofibroblast proliferation, and fibrosis in obstructing colon carcinoma: the roles of Hsp47 and basic fibroblast growth factor. Pathology. 2013;209(2):69\u201374.","journal-title":"Pathology"},{"issue":"6","key":"4386_CR23","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s10620-015-3552-9","volume":"60","author":"AC Baird","year":"2015","unstructured":"Baird AC, Lloyd F, Lawrance IC. Prostaglandin E2 and polyenylphosphatidylcholine protect against intestinal fibrosis and regulate myofibroblast function. Dig Dis Sci. 2015;60(6):1603\u201316.","journal-title":"Dig Dis Sci"},{"issue":"20","key":"4386_CR24","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/sim.2174","volume":"24","author":"J Xie","year":"2005","unstructured":"Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24(20):3089\u2013110.","journal-title":"Stat Med"},{"issue":"23","key":"4386_CR25","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1001\/jama.2016.17396","volume":"316","author":"AM Grool","year":"2016","unstructured":"Grool AM, Aglipay M, Momoli F, Meehan WP 3rd, Freedman SB, Yeates KO, et al. Association between early participation in physical activity following acute concussion and persistent postconcussive symptoms in children and adolescents. JAMA. 2016;316(23):2504\u201314.","journal-title":"JAMA"},{"issue":"1","key":"4386_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/apt.14092","volume":"46","author":"WT van Haaften","year":"2017","unstructured":"van Haaften WT, Mortensen JH, Karsdal MA, Bay-Jensen AC, Dijkstra G, Olinga P. Misbalance in type III collagen formation\/degradation as a novel serological biomarker for penetrating (Montreal B3) crohn\u2019s disease. Aliment Pharmacol Ther. 2017;46(1):26\u201339.","journal-title":"Aliment Pharmacol Ther"},{"key":"4386_CR27","doi-asserted-by":"crossref","unstructured":"Burke JP, Mulsow JJ, O\u2019Keane C, Docherty NG, Watson RWG, O\u2019Connell PR. Fibrogenesis in Crohn\u2019s Disease. Official J Am Coll Gastroenterol | ACG. 2007;102(2):439\u2013448.","DOI":"10.1111\/j.1572-0241.2006.01010.x"},{"issue":"3","key":"4386_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/MIB.0000000000000716","volume":"22","author":"R Meier","year":"2016","unstructured":"Meier R, Lutz C, Cos\u00edn-Roger J, Fagagnini S, Bollmann G, H\u00fcnerwadel A, et al. Decreased fibrogenesis after treatment with Pirfenidone in a newly developed mouse model of intestinal fibrosis. Inflamm Bowel Dis. 2016;22(3):569\u201382.","journal-title":"Inflamm Bowel Dis"},{"key":"4386_CR29","doi-asserted-by":"crossref","unstructured":"van Haaften WT, Mortensen JH, Dige AK, Gr\u00f8nb\u00e6k H, Hvas CL, Bay-Jensen A-C et al. Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn\u2019s Disease: A Pilot Study. Clin Translational Gastroenterol. 2020;11(9):e00217.","DOI":"10.14309\/ctg.0000000000000217"},{"issue":"5","key":"4386_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4386_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/cei.12084","volume":"173","author":"C Liu","year":"2013","unstructured":"Liu C, Xia X, Wu W, Wu R, Tang M, Chen T, et al. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn\u2019s disease. Clin Exp Immunol. 2013;173(1):102\u201311.","journal-title":"Clin Exp Immunol"},{"key":"4386_CR32","doi-asserted-by":"crossref","unstructured":"Bertin L, Barberio B, Gubbiotti A, Bertani L, Costa F, Ceccarelli L et al. Association between ustekinumab trough levels, serum IL-22, and Oncostatin M levels and clinical and biochemical outcomes in patients with crohn\u2019s disease. J Clin Med. 2024; 13(6).","DOI":"10.3390\/jcm13061539"},{"issue":"7","key":"4386_CR33","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/MIB.0000000000000043","volume":"20","author":"C Li","year":"2014","unstructured":"Li C, Kuemmerle JF. Mechanisms that mediate the development of fibrosis in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2014;20(7):1250\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"4386_CR34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/apt.14852","volume":"48","author":"S Singh","year":"2018","unstructured":"Singh S, Fumery M, Sandborn WJ, Murad MH. Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn\u2019s disease. Aliment Pharmacol Ther. 2018;48(4):394\u2013409.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"4386_CR35","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/apt.16551","volume":"54","author":"K Takenaka","year":"2021","unstructured":"Takenaka K, Kawamoto A, Hibiya S, Suzuki K, Fujii T, Motobayashi M, et al. Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in crohn\u2019s disease. Aliment Pharmacol Ther. 2021;54(8):1052\u201360.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"4386_CR36","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cgh.2019.08.024","volume":"18","author":"K Takenaka","year":"2020","unstructured":"Takenaka K, Fujii T, Suzuki K, Shimizu H, Motobayashi M, Hibiya S, et al. Small bowel healing detected by endoscopy in patients with Crohn\u2019s disease after treatment with antibodies against tumor necrosis factor. Clin Gastroenterol Hepatol. 2020;18(7):1545\u201352.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4386_CR37","doi-asserted-by":"crossref","unstructured":"Takenaka K, Hisamatsu T, Kobayashi T, Yamamoto H, Ohmiya N, Hayashi R, et al. Inadequate efficacy of biologics for treating proximal ileal lesions in crohn\u2019s Disease; A prospective multicenter study.\u00a0Clin Gastroenterol Hepatol. 2025;23(11):1991\u20132000.","DOI":"10.1016\/j.cgh.2024.10.030"},{"key":"4386_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/JIR.S157358","volume":"11","author":"PG Kotze","year":"2018","unstructured":"Kotze PG, Ma C, Almutairdi A, Panaccione R. Clinical utility of ustekinumab in Crohn\u2019s disease. J Inflamm Res. 2018;11:35\u201347.","journal-title":"J Inflamm Res"},{"issue":"8","key":"4386_CR39","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41590-019-0415-0","volume":"20","author":"MF Neurath","year":"2019","unstructured":"Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20(8):970\u20139.","journal-title":"Nat Immunol"},{"issue":"1","key":"4386_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-118","volume":"14","author":"JR Johnson","year":"2013","unstructured":"Johnson JR, Nishioka M, Chakir J, Risse P-A, Almaghlouth I, Bazarbashi AN, et al. IL-22 contributes to TGF-\u03b21-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells. Respir Res. 2013;14(1):118.","journal-title":"Respir Res"},{"key":"4386_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aar7754","author":"T Fabre","year":"2018","unstructured":"Fabre T, Molina MF, Soucy G, Goulet JP, Willems B, Villeneuve JP, et al. Type 3 cytokines IL-17A and IL-22 drive TGF-\u03b2-dependent liver fibrosis. Sci Immunol. 2018. https:\/\/doi.org\/10.1126\/sciimmunol.aar7754.","journal-title":"Sci Immunol"},{"issue":"8b","key":"4386_CR42","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/j.1582-4934.2008.00647.x","volume":"13","author":"DE Sullivan","year":"2009","unstructured":"Sullivan DE, Ferris M, Nguyen H, Abboud E, Brody AR. TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med. 2009;13(8b):1866\u201376.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4386_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s41385-019-0146-4","volume":"12","author":"R Mathur","year":"2019","unstructured":"Mathur R, Alam MM, Zhao X-F, Liao Y, Shen J, Morgan S, et al. Induction of autophagy in Cx3cr1\u2009+\u2009mononuclear cells limits IL-23\/IL-22 axis-mediated intestinal fibrosis. Mucosal Immunol. 2019;12(3):612\u201323.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"4386_CR44","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jss.2016.04.034","volume":"204","author":"S Saini","year":"2016","unstructured":"Saini S, Liu T, Yoo J. TNF-\u03b1 stimulates colonic myofibroblast migration via COX-2 and Hsp27. J Surg Res. 2016;204(1):145\u201352.","journal-title":"J Surg Res"},{"issue":"3","key":"4386_CR45","doi-asserted-by":"publisher","first-page":"G809","DOI":"10.1152\/ajpgi.00057.2002","volume":"283","author":"JG Simmons","year":"2002","unstructured":"Simmons JG, Pucilowska JB, Keku TO, Lund PK. IGF-I and TGF-\u03b21 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiology-Gastrointestinal Liver Physiol. 2002;283(3):G809-18.","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"issue":"2","key":"4386_CR46","doi-asserted-by":"publisher","first-page":"C183","DOI":"10.1152\/ajpcell.1999.277.2.C183","volume":"277","author":"DW Powell","year":"1999","unstructured":"Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. part II. intestinal subepithelial myofibroblasts. Am J Physiol. 1999;277(2):C183-201.","journal-title":"Am J Physiol"},{"issue":"6","key":"4386_CR47","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","volume":"29","author":"LA Zenewicz","year":"2008","unstructured":"Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008;29(6):947\u201357.","journal-title":"Immunity"},{"issue":"3","key":"4386_CR48","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/gutjnl-2019-318483","volume":"69","author":"N Powell","year":"2020","unstructured":"Powell N, Pantazi E, Pavlidis P, Tsakmaki A, Li K, Yang F, et al. Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells. Gut. 2020;69(3):578.","journal-title":"Gut"},{"issue":"1","key":"4386_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.clim.2015.03.003","volume":"158","author":"L-Y Wu","year":"2015","unstructured":"Wu L-Y, Liu S, Liu Y, Guo C, Li H, Li W, et al. Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis c. Clin Immunol. 2015;158(1):77\u201387.","journal-title":"Clin Immunol"},{"issue":"9317","key":"4386_CR50","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","volume":"359","author":"SB Hanauer","year":"2002","unstructured":"Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for crohn\u2019s disease: the ACCENT I randomised trial. Lancet. 2002;359(9317):1541\u20139.","journal-title":"Lancet"},{"issue":"1","key":"4386_CR51","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","volume":"132","author":"JF Colombel","year":"2007","unstructured":"Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, et al. Adalimumab for maintenance of clinical response and remission in patients with crohn\u2019s disease: the CHARM trial. Gastroenterology. 2007;132(1):52\u201365.","journal-title":"Gastroenterology"},{"issue":"7","key":"4386_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00535-017-1350-1","volume":"52","author":"S Ihara","year":"2017","unstructured":"Ihara S, Hirata Y, Koike K. TGF-\u03b2 in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J Gastroenterol. 2017;52(7):777\u201387.","journal-title":"J Gastroenterol"},{"issue":"1","key":"4386_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cgh.2016.08.015","volume":"15","author":"T Arai","year":"2017","unstructured":"Arai T, Takeuchi K, Miyamura M, Ishikawa R, Yamada A, Katsumata M, et al. Level of fecal calprotectin correlates with severity of small bowel Crohn\u2019s disease, measured by balloon-assisted enteroscopy and computed tomography enterography. Clin Gastroenterol Hepatol. 2017;15(1):56\u201362.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"4386_CR54","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/0016-5085(90)90613-6","volume":"99","author":"P Rutgeerts","year":"1990","unstructured":"Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn\u2019s disease. Gastroenterology. 1990;99(4):956\u201363.","journal-title":"Gastroenterology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04386-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04386-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04386-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:03:18Z","timestamp":1762934598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04386-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4386"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04386-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Osaka Metropolitan University Graduate School of Medicine Ethics Committee (number 2021\u2009\u2212\u2009227, approved on April 20, 2020). Informed consent was obtained from all participants, and information regarding this study was also publicly available online.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"785"}}